Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Performance
Today’s low
235.00Today’s High
249.0052W low
137.5052W High
304.00Open Price
249.00Prev. Close
210.5000Volume
1000.00Value
235000.00Fundamentals
Market Cap
471.20
Price to Earnings
57.10
Price to Book Value
7.50
Dividend Yield
0.00
PE to Growth
4.10
Op Revenue TTM
72.84
Net Profit TTM
8.25
Cash From Operating Activity
-8.24
Return on Equity %
13.15
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
26 Jul, 2024
100
Week
81.8
Month
79.9
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
239.67
PIVOT
First Resistance
244.33
Second Resistance
253.67
Third Resistance
258.33
First Support
230.33
Second Support
225.67
Third Support
216.33
Relative Strength Index
62.7
Money Flow Index
75.39
MACD
1.24
MACD Signal
-0.79
Average True Range
11.35
Average Directional Index
15.52
Rate of Change (21)
2.62
Rate of Change (125)
-1.94
Commodity Channel Index
236
Williams %R
-29.5
BETA
1 Month
0.84
3 Month
-0.47
1 Year
0.21
3 Year
0.48
PRICE CHANGE ANALYSIS
↑ 9.81%
1 Week
Low
High
212
249
↑ 6.07%
1 Month
Low
High
201.5
249
↓ 0%
3 Months
Low
High
189
269
↓ -2.49%
6 Months
Low
High
180
269.5
↑ 53.8%
1 Year
Low
High
137.5
303.95
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Graph |
|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 15.98 | 22.19 | 15.82 | 19.17 | 18.13 | 15.51 | 13.75 | 14.38 | |
| Operating Expenses Qtr | 14.80 | 17.87 | 13.22 | 16.15 | 15.45 | 13.01 | 11.76 | 12.14 | |
| Operating Profit Qtr | 0.97 | 4.24 | 2.59 | 2.99 | 2.66 | 2.49 | 1.99 | 2.24 | |
| EBIDT Qtr Cr | 1.18 | 4.32 | 2.60 | 3.02 | 2.68 | 2.49 | 1.99 | 2.24 | |
| Depreciation Qtr | 0.20 | 0.19 | 0.21 | 0.20 | 0.26 | 0.24 | 0.17 | 0.16 | |
| Net Profit Qtr | 0.52 | 3.68 | 1.67 | 2.37 | 2.10 | 2.04 | 1.30 | 1.80 | |
| Basic EPS Qtr | 0.26 | 1.84 | 0.83 | 2.37 | 2.09 | 2.04 | 1.29 | 1.96 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 73.16 | 61.77 | 50.24 | 40.13 | 39.77 | |
| Operating Expenses Annual Cr | 62.04 | 52.37 | 43.15 | 34.59 | 35.80 | |
| Operating Profit Annual | 10.80 | 9.38 | 6.91 | 5.50 | 3.96 | |
| Operating Profit Margin Annual % | 14.76 | 15.18 | 13.75 | 13.70 | 9.97 | |
| Total Expenses Annual Cr | 64.35 | 54.38 | 44.75 | 36.00 | 36.90 | |
| EBIDT Annual Cr | 11.11 | 9.40 | 7.09 | 5.54 | 3.97 | |
| EBIDT Annual margin % | 15.19 | 15.21 | 14.11 | 13.81 | 9.99 | |
| Depreciation | 0.80 | 0.83 | 0.42 | 0.25 | 0.21 | |
| PAT Before ExtraOrdinary Items Annual Cr | 8.25 | 7.24 | 5.24 | 5.10 | 2.54 | |
| Net Profit Annual | 8.25 | 7.24 | 5.24 | 5.10 | 2.53 | |
| Basic EPS Annual | 4.11 | 7.51 | 8.56 | 8.40 | 4.18 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 62.75 | 54.50 | 38.88 | 21.54 | 16.44 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 4.25 | 2.68 | 4.49 | 4.13 | 1.22 | |
| Total Current Liabilities Annual Cr | 17.46 | 12.29 | 12.21 | 18.01 | 17.04 | |
| Total Capital Plus Liabilities Annual Cr | 84.46 | 69.47 | 55.57 | 43.68 | 34.70 | |
| Fixed Assets Annual | 10.47 | 8.73 | 7.86 | 4.32 | 2.68 | |
| Total Non Current Assets Annual | 11.37 | 9.56 | 8.77 | 5.55 | 2.80 | |
| Total Current Assets Annual | 73.09 | 59.91 | 46.80 | 38.13 | 31.90 | |
| Total Assets Annual | 84.46 | 69.47 | 55.57 | 43.68 | 34.70 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 1.19 | 0.70 | 0.00 | 0.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | -8.24 | 0.53 | 2.91 | 0.22 | -0.79 | |
| Cash from Investing Activity Annual | 9.50 | -6.67 | -5.40 | -1.75 | -0.59 | |
| Cash from Financing Annual Activity | 4.24 | 6.29 | 2.41 | 1.46 | 1.49 | |
| Net Cash Flow Annual | 5.49 | 0.14 | -0.08 | -0.07 | 0.12 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 31.29 | 54.35 | 42.41 | 35.50 | 27.10 | |
| ROE Annual % | 13.15 | 13.28 | 13.47 | 23.66 | 15.41 | |
| ROCE Annual % | 15.39 | 14.99 | 15.37 | 20.61 | 21.28 | |
| Total Debt to Total Equity Annual | 0.23 | 0.21 | 0.32 | 0.49 | 0.48 | |
| EBDIT Annual Margin % | 15.26 | 15.21 | 14.16 | 13.82 | 9.98 |
| Indicator | Graph |
|---|---|
| Total Qtr Revenue cr | |
| Operating Expenses Qtr | |
| Operating Profit Qtr | |
| EBIDT Qtr Cr | |
| Depreciation Qtr | |
| Net Profit Qtr | |
| Basic EPS Qtr |
| Indicator | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|
| Total Revenue Annual | 50.24 | 40.15 | 39.77 | |
| Operating Expenses Annual Cr | 43.31 | 34.80 | 35.84 | |
| Operating Profit Annual | 6.75 | 5.31 | 3.93 | |
| Operating Profit Margin Annual % | 13.44 | 13.23 | 9.87 | |
| Total Expenses Annual Cr | 44.93 | 36.22 | 36.90 | |
| EBIDT Annual Cr | 6.93 | 5.35 | 3.93 | |
| EBIDT Annual margin % | 13.80 | 13.33 | 9.89 | |
| Depreciation | 0.45 | 0.26 | 0.21 | |
| PAT Before ExtraOrdinary Items Annual Cr | 5.06 | 4.90 | 2.54 | |
| Net Profit Annual | 5.06 | 4.90 | 2.53 | |
| Basic EPS Annual | 8.27 | 8.07 | 4.18 |
| Indicator | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|
| Total ShareHolders Funds Annual | 38.51 | 21.34 | 16.44 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 4.82 | 4.22 | 1.52 | |
| Total Current Liabilities Annual Cr | 12.28 | 18.14 | 16.73 | |
| Total Capital Plus Liabilities Annual Cr | 55.62 | 43.71 | 34.70 | |
| Fixed Assets Annual | 7.88 | 4.36 | 2.68 | |
| Total Non Current Assets Annual | 8.78 | 5.57 | 2.80 | |
| Total Current Assets Annual | 46.84 | 38.13 | 31.90 | |
| Total Assets Annual | 55.62 | 43.71 | 34.70 | |
| Contingent Liabilities plus Commitments Annual Cr | 0.70 | 0.83 | 3.18 |
| Indicator | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|
| Cash from Operating Activity Annual | 2.70 | 0.16 | -0.84 | |
| Cash from Investing Activity Annual | -5.44 | -1.78 | -0.57 | |
| Cash from Financing Annual Activity | 2.65 | 1.55 | 1.53 | |
| Net Cash Flow Annual | -0.09 | -0.07 | 0.12 |
| Indicator | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|
| Book Value Per Share Annual | 42.01 | 35.17 | 27.10 | |
| ROE Annual % | 13.14 | 22.95 | 15.41 | |
| ROCE Annual % | 14.97 | 19.93 | 20.70 | |
| Total Debt to Total Equity Annual | 0.33 | 0.50 | 0.48 | |
| EBDIT Annual Margin % | 13.85 | 13.34 | 9.89 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| JAGDISHKUMAR DEVJIBHAI AJUDIYA | 48.82 | 89032027 | 0 | 2.04 |
| AJUDIA JAGDISH DEVJIBHAI HUF | 5.74 | 89032028 | 0 | 100 |
| MALTI JAGDISHBHAI AJUDIA | 2.91 | 89032029 | 0 | 34.24 |
| PRIYANKA JAGDISHBHAI AJUDIA | 1.99 | 89032030 | 0 | 25 |
| INDO US AGRISEEDS LIMITED | 10.71 | 89032034 | 0 | 83.23 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| PRATIK RAJENDRABHAI GANDHI | 1.5 | 89032045 |
| NATVARSINH T CHAVDA . | 1.1 | 89032046 |
| NITIN DALPATLAL SHAH | 1.06 | 89032047 |
| HUF | 1.74 | 89032037 |
| IMPROWISED TECHNOLOGIES PRIVATE | 1.99 | 89032041 |
| AUMIT CAPITAL ADVISORS LIMITED | 1.08 | 89032042 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Oct 28, 2021 | 0.25 | INTERIM | Oct 29, 2021 | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 02, 2024 | Audited Results | - |
| Feb 14, 2024 | Quarterly Results | - |
| Nov 08, 2023 | Quarterly Results | - |
| Aug 12, 2023 | Quarterly Results | - |
| Jul 07, 2023 | Bonus issue | - |
| May 03, 2023 | Quarterly Results | - |
| Dec 30, 2022 | Others | Inter alia, to consider : 1. The Migration of listing/trading of equity shares of the Company from BSE SME (SME Platform BSE) to the Main Board of NSE and BSE subject to the approval of shareholders |
| Nov 14, 2022 | Half Yearly Results | - |
| Jul 28, 2022 | Others | Inter alia, to consider and approve the transfer of 98.5% equity stake (i.e., 9850 equity shares) in its subsidiary Company i.e., AGRIPARI E-COMMERCE PRIVATE LIMITED. |
| Jul 08, 2022 | Preferential issue of shares & A.G.M. | (Revised) |
| May 30, 2022 | Audited Results | - |
| May 02, 2022 | Others | Inter alia, to consider for the purpose of Calling the Extra Ordinary General Meeting and Any other Matter with the permission of the Chair. |
| Nov 14, 2021 | Quarterly Results | - |
| Oct 19, 2021 | Interim Dividend | - |
| Oct 09, 2021 | Bonus issue & Interim Dividend | - |
| Sep 01, 2021 | Others | inter alia, to consider 1. To fix date and time for conducting the AGM through video conferencing (VC)/other Audio-Visual Means (OAVM) for the financial year ended on 31.03.21. |
| Jun 30, 2021 | Audited Results | - |
| Nov 13, 2020 | Quarterly Results | - |
| Sep 02, 2020 | Others | - |
| Jun 30, 2020 | Audited Results | (Revised) |
| Jun 22, 2020 | Audited Results | - |
| Jun 10, 2020 | Others | Inter alia, 1. The incorporation of Wholly Owned Subsidiary ("WOS") of the Company, named, "Agripari E-commerce Private Limited." |
| Jan 24, 2020 | Others | inter alia, to consider and approve appointment of Ms. Dimpy Joshi, a qualified Company Secretary as a Company Secretary and Compliance Officer of the Company. |
| Nov 14, 2019 | Half Yearly Results | - |
| Aug 23, 2019 | Issue Of Warrants | inter alia, to consider and approve Revision in the size of Preferential issue of Share Warrants. |
| Aug 09, 2019 | Issue Of Warrants | - |
| May 30, 2019 | Audited Results | - |
| Mar 07, 2019 | Bonus issue & Others | Increase in Authorised Capital |
| Nov 14, 2018 | Quarterly Results | - |
| Jul 20, 2018 | Audited Results | (Revised) |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Aug 29, 2023 | 1:1 | 2023-08-29 |
| Nov 29, 2021 | 1:5 | 2021-11-30 |
| Apr 23, 2019 | 1:4 | 2019-04-24 |
15 Jul 2024
Indo Us Bio-Tech Ltd - 541304 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74(5) of SEBI DP Regulation for the quarter ended on 30th June, 2024.
21 Jun 2024
Indo Us Bio-Tech Ltd - 541304 - Announcement Under Regulation 30 (LODR) (Clarification Letter For Error In Standalone Result Filled For The Quarter And Half Year Ended September 30, 2023)
Clarification regarding error in standalone financial results for the quarter and half year ended 30th September, 2023.
21 May 2024
Indo Us Bio-Tech Ltd - 541304 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report of the company for the period ended on 31st march, 2024.
21 May 2024
Indo Us Bio-Tech Ltd - 541304 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report of the company for the period ended on 31st march, 2024.
17 May 2024
Indo Us Bio-Tech Ltd - 541304 - Revised Financial Results For The Period Of March 31, 2024
We are submitting the Revised Financial Results; The statement of Standalone Audited Financial Results of the Company for the period of March 31, 2024.
03 May 2024
Indo Us Bio-Tech Ltd - 541304 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Audited Financial Results for the Quarter and Year ended on 31st March, 2024.
02 May 2024
Indo Us Bio-Tech Ltd - 541304 - Results-Financial Results For March 31, 2024
Audited Financial Results for the year ended on 31st March, 2024.
02 May 2024
Indo Us Bio-Tech Ltd - 541304 - Board Meeting Outcome for Submission Of Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March, 2024.
With reference to above, we hereby inform that meeting of Board of Directors of the Company held today (i.e., 02/05/2024), in which Board has approved and adopted the standalone Audited Financial Results of the Company for the Quarter and year ended 31st March, 2024. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the following: 1. Standalone Audited Financial Results of the Company for quarter and year ended on 31st March, 2024. 2. Auditors'' Report on Standalone Audited Financial Results. These are also being made available on the website of the Company at www.indousagriseeds.com
25 Apr 2024
Indo Us Bio-Tech Ltd - 541304 - Board Meeting Intimation for Considering And Approving The Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2024.
Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 ,inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2024.
